Mark Augusti

Mark Augusti

Chief Executive Officer bij AdvaMed Accel

Vermogen: - $ op 30-09-2023

58 jaar
Health Technology
Consumer Services
Electronic Technology

Profiel

Mark A.
Augusti
is the President, Chief Executive Officer & Director of AdvaMed Accel.
He was previously the President, Chief Executive Officer & Director of ConforMIS, Inc. from 2016 to 2023, and the President & Chief Executive Officer of Bioventus LLC in 2012-2013.
He served as an Independent Director at Hutchinson Technology, Inc. from 2011 to 2012.
From 2014 to 2016, he was the VP, President-Orthopedics & Tissue Technologies at Integra LifeSciences Holdings Corp.
He was also a Vice President at JPMorgan Chase & Co. in 2003.
From 2003 to 2012, he was the President-Biologics & Clinical Therapies at Smith & Nephew plc.
Augusti received his undergraduate degree from Duke University and his MBA from UCLA Anderson School of Management.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
05-09-2023 0 ( -.--% ) - $ 30-09-2023

Actieve functies van Mark Augusti

BedrijvenFunctieBegin
Chief Executive Officer -
Alle actieve functies van Mark Augusti

Eerdere bekende functies van Mark Augusti

BedrijvenFunctieEinde
CONFORMIS, INC. Chief Executive Officer 05-09-2023
INTEGRA LIFESCIENCES HOLDINGS CORPORATION Corporate Officer/Principal 11-11-2016
HUTCHINSON TECHNOLOGY INCORPORATED Director/Board Member 09-05-2012
SMITH & NEPHEW PLC Corporate Officer/Principal 01-04-2012
JPMORGAN CHASE & CO. Corporate Officer/Principal 01-01-2003
Ervaring van Mark Augusti in detail bekijken

Opleiding van Mark Augusti

Duke University Undergraduate Degree
UCLA Anderson School of Management Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Augusti in detail bekijken

Connecties

100 +

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Health Technology

JPMORGAN CHASE & CO.

Finance

SMITH & NEPHEW PLC

Health Technology

CONFORMIS, INC.

Health Technology

Bedrijven in privébezit3

Electronic Technology

Health Technology

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Augusti